Company Filing History:
Years Active: 1999
Title: Barry Michael Woloski: Innovator in HIV Therapeutics
Introduction
Barry Michael Woloski is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of medical science, particularly in the area of HIV therapeutics. His innovative approach has the potential to impact the lives of many individuals exposed to or infected by the virus.
Latest Patents
Woloski holds a patent for a method aimed at delaying the progression of infection with the Human Immunodeficiency Virus (HIV). This patent, titled "Therapeutic and prophylactic methods using Rh antibodies for delaying the progression of infection with the Human Immunodeficiency Virus (HIV) in a subject who is exposed to HIV, or infected by HIV," showcases his commitment to advancing healthcare solutions. He has 1 patent to his name.
Career Highlights
Woloski is associated with Cangene Corporation, a company known for its focus on developing therapeutic products. His work at Cangene has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical science.
Collaborations
One of his notable coworkers is Christos M Tsoukas, with whom he has likely shared insights and expertise in their joint efforts to combat HIV.
Conclusion
Barry Michael Woloski's innovative work in HIV therapeutics exemplifies the impact that dedicated inventors can have on public health. His contributions are paving the way for new methods of treatment and prevention.